Monday, September 30, 2024
HomeTagsOmeros

Omeros

Omeros Confirms Submission of Response to FDA Regarding the BLA for Narsoplimab in the Treatment of HSCT-TMA

Omeros Corporation confirmed that earlier this month the company submitted to the U.S. Food and Drug Administration (FDA) its response to the Agency’s Complete...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics